The U.S. based medical device company manufactures the AeroForm Tissue Expander System used for breast reconstruction.
AirXpanders’ contract manufacturer, MedPlast, is a services provider to the medical device industry and operates 23 manufacturing facilities around the world.
The AeroForm Tissue Expander offers a needle-free alternative for women who choose reconstructive surgery following a mastectomy.
The device is activated by a handheld wireless controller that administers small amounts of carbon dioxide (CO2) up to three times a day, to gradually stretch the tissue to prepare for a breast implant.
With the push of a button from the controller, a pre-programmed amount of CO2 is delivered in seconds, allowing the patient to continue with her daily activities while preparing for reconstruction.
AirXpander’ production line has a capacity to produce up to 20,000 units per year. This should meet the growing market demand for the product, which is now available in more than 100 U.S. hospitals.
Additionally, AirXpanders will maintain its existing manufacturing facility in California with a capacity of up to 4,000 units per year.
The increased production capacity should enable the company to cost-effectively manufacture a higher volume of AeroForm expanders.
The company’s shares were last trading at $0.785, an increase of circa 14% during the last one month.